The Group was first established in 2013 and has grown from a single product UK-based NIPT company to a leading international genomic medicine company with over 100 products and services.
Our name may have evolved but our mission has always remained true.
ENABLING SCIENTIFIC ADVANCES TO POSITIVELY IMPACT HUMAN HEALTH
Our Growth Story
Have a look below at our strategic growth story over the last ten years.
Premaitha was the first to market a CE-IVD kitted product for NIPT - changing the landscape of prenatal screening
Premaitha acquired Taiwanese Yourgene Bioscience to enter Asia market for NIPT and expansion of clinical services
Yourgene Health rebranded to reflect the groups broadened product and service capabilities
Acquisition of Elucigene to strengthen the reproductive and precision medicine product portfolio including screening kits for cystic fibrosis
Acquisition of Ex5 Genomics to expand the clinical and research services expertise and capabilities to enable a broader menu portfolio for our customers
Acquisition of Coastal Genomics to enhance our technology and IP in the field of DNA sample preparation for NIPT and future applications, enabling geographic expansion into the Americas
Yourgene Genomic Services
Launch of focused Genomic Services offering, consolidating on UK and Taiwan services to give a comprehensive solution to clinical, research and pharma organisations
An integrated technologies and service business, enabling the delivery of genomic medicine with over 100 products and services for a global market
Yourgene Health is a leading international molecular diagnostics group with an integrated portfolio of technologies and services to enable genomic medicine.
Our mission to enable scientific advances to positively impact human health remains at the core of our focus. It drives and motivates us to develop class leading products and services to meet our customers needs.
Yourgene has a comprehensive offering of non-invasive prenatal tests (NIPT) NGS workflows that have been built with labs in mind, and clinical prenatal screening services. The IONA® test was the pioneer, the first to market as an IVD product, changing the NIPT screening landscape back in 2015.
Continuing to build on our expertise in cell-free DNA, our next generation size selection Ranger® Technology uses machine vision for superior precision. With multiple platforms for a range of clinical and research cfDNA sample preparation applications including NIPT, liquid biopsy, oncology and gene synthesis.
In addition, we offer a portfolio of screening products in reproductive health and precision medicine including assays for cystic fibrosis and DPYD genotyping to prevent chemotoxicity.
Yourgene is an AIM listed public company (YGEN) headquartered in Manchester, UK with locations in Vancouver, US, Singapore and Taiwan.
Follow us on LinkedIn to learn more